These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 19842982)

  • 1. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.
    Chen TY; Ding EL; Seage Iii GR; Kim AY
    Clin Infect Dis; 2009 Nov; 49(10):1605-15. PubMed ID: 19842982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.
    Smit C; van den Berg C; Geskus R; Berkhout B; Coutinho R; Prins M
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):221-5. PubMed ID: 18223361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study.
    Anderson KB; Guest JL; Rimland D
    Clin Infect Dis; 2004 Nov; 39(10):1507-13. PubMed ID: 15546088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.
    Butt AA; Fultz SL; Kwoh CK; Kelley D; Skanderson M; Justice AC
    Hepatology; 2004 Jul; 40(1):115-9. PubMed ID: 15239093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.
    Klein MB; Lalonde RG; Suissa S
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):365-72. PubMed ID: 12843748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?
    Verma S; Wang CH; Govindarajan S; Kanel G; Squires K; Bonacini M
    Clin Infect Dis; 2006 Jan; 42(2):262-70. PubMed ID: 16355339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
    Qurishi N; Kreuzberg C; Lüchters G; Effenberger W; Kupfer B; Sauerbruch T; Rockstroh JK; Spengler U
    Lancet; 2003 Nov; 362(9397):1708-13. PubMed ID: 14643119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
    PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy.
    Backus LI; Phillips BR; Boothroyd DB; Mole LA; Burgess J; Rigsby MO; Chang SW
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):613-9. PubMed ID: 16044016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.
    Mahure SA; Bosco JA; Slover JD; Vigdorchik J; Iorio R; Schwarzkopf R
    Clin Orthop Relat Res; 2018 Feb; 476(2):356-369. PubMed ID: 29529669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early initiation of antiretroviral therapy: the current best way to reduce liver-related deaths in HIV/hepatitis C virus-coinfected patients.
    Shafran SD
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):551-6. PubMed ID: 17224846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.
    Tsiara CG; Nikolopoulos GK; Dimou NL; Bagos PG; Saroglou G; Velonakis E; Hatzakis A
    J Viral Hepat; 2013 Oct; 20(10):715-24. PubMed ID: 24010646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
    Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
    Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis.
    Miller MF; Haley C; Koziel MJ; Rowley CF
    Clin Infect Dis; 2005 Sep; 41(5):713-20. PubMed ID: 16080095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.